Highlights from the 10th Breast, Gynaecological and Immunotherapy International Cancer Conference (BGICC), 18-19 January 2018, Cairo, Egypt

Hesham El-Ghazaly; Adel Aref; Nermeen Bahie-Eldin

doi:10.3332/ecancer.2018.820

Highlights from the 10th Breast, Gynaecological and Immunotherapy International Cancer Conference (BGICC), 18-19 January 2018, Cairo, Egypt

Ecancermedicalscience. 2018 Mar 22:12:820. doi: 10.3332/ecancer.2018.820. eCollection 2018.

Authors

Hesham El-Ghazaly^{1

2}, Adel Aref^{1

3}, Nermeen Bahie-Eldin^{1

2}

Affiliations

¹ Breast and Gynaecological International Cancer Society (BGICS), Cairo 11757, Egypt.
² Clinical Oncology department, Ain Shams University, Cairo 11566, Egypt.
³ University of Adelaide Medical School, Adelaide 5000, Australia.

Abstract

During the 10th Breast, Gynaecological and Immunotherapy International Cancer Conference (BGICC), which was held on 18 and 19 of January, 2018, in Cairo, Egypt, around 100 international, regional and national experts presented the latest updates in breast cancer, gynaecological cancers and immunotherapy in oncology. Through this report, we will try to highlight the important data and consensus issues that were discussed during the conference.

Keywords: BGICC; BGICS; breast cancer; gynaecological cancer; immunotherapy.